selumetinib 25 mg uses

Default sorting
Show
12
  • Quick View
    Research Products

    Koselugo 25mg

    Generic name: Selumetinib
    Dosage form: Capsule
    Drug class: Multikinase inhibitors

    What is Koselugo?

    Koselugo is a targeted therapy developed by AstraZeneca and licensed from Array BioPharma (a subsidiary of Pfizer). It is the first FDA-approved treatment specifically for NF1-related plexiform neurofibromas.

    Call for Price